Related Experiment Videos
Increased frequency of the C4A*6 rare allele in rheumatic heart disease
I J de Messias1, E Cavalcanti, S C Radominski
1Departamento de Patologia Clinica, Hospital de Clinicas da Universidade Federal do Parana, Brazil.
Insights
The study found rare C4A*6 alleles were more common in Brazilian Rheumatic Heart Disease (RHD) patients, suggesting it may be a genetic marker for RHD. Further research is needed to confirm this association.
Area of Science:
- Immunogenetics
- Molecular Biology
- Cardiovascular Disease Research
Background:
- Rheumatic Heart Disease (RHD) is a significant global health concern.
- The Major Histocompatibility Complex (MHC) class III region contains genes for complement proteins (BF, C2, C4) involved in immune responses.
- Genetic variations in these complement proteins may influence susceptibility to or progression of RHD.
Purpose of the Study:
- To investigate the association between alleles of MHC class III complement proteins (BF, C2, C4A, C4B) and Rheumatic Heart Disease (RHD) in a Brazilian population.
- To determine if specific complement protein alleles could serve as genetic markers for RHD.
- To compare allele frequencies between RHD patients and healthy controls.
Main Methods:
- Case-control study design involving 49 RHD patients and 65 healthy controls from Brazil.
- Allotyping of complement proteins BF, C2, C4A, and C4B using standard biochemical techniques.
- Western blot analysis with specific antibodies was employed for C2 and C4 variant determination.
Main Results:
- A statistically significant increase in the frequency of the rare C4A*6 allele was observed in RHD patients (p = 0.003, Relative Risk = 11.85).
- A decrease in the C4A*3 allele frequency was noted in the patient group.
- Null alleles for C4 and rare alleles for BF and C4 were found to be more prevalent in RHD patients compared to controls.
Conclusions:
- The rare C4A*6 allele shows a strong association with RHD in the studied Brazilian population.
- The findings suggest that C4A*6 may potentially be a genetic marker for RHD.
- Further investigation is required to ascertain if C4A*6 is specifically linked to the cardiac manifestations of the disease or RHD itself.
Abstract:
The aim of the present investigation was to determine whether the alleles of the MHC class III complement proteins BF, C2 and C4 (C4A and C4B) could be markers for RHD in the Brazilian population. Forty-nine patients with chronic RHD were studied. The controls included 65 healthy unrelated individuals, matched with the patients according to sex, age and ethnical background. BF, C2, C4A and C4B allotypes were determined by standard technologies including Western blots for C2 and C4 variants with monoclonal and policlonal antibodies. The results showed a significantly elevated presence of the C4A*6 rare allele (p = 0.003 RR = 11.85) and a decrease of C4A*3 in the patients. In addition, C4 null and BF and C4 rare alleles were more frequent in patients than in the controls. Considering that in this investigation only RHD patients were included, further studies are necessary in order to clarify whether C4A6 is a marker for the cardiac form or for the disease itself.